Novel temperature-triggered liposome with high stability: Formulation, <i>in vitro</i> evaluation, and <i>in vivo</i> study combined with high-intensity focused ultrasound (HIFU)

  • Park, Sun Min; 
  • Kim, Min Sang; 
  • Park, Sang-Jun; 
  • Park, Eun Sung; 
  • Choi, Kyu-Sil; 
  • 외 2명
Citations

WEB OF SCIENCE

131
Citations

SCOPUS

144

초록

We developed a novel temperature-sensitive liposome, STL composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-PEG-(2000)), cholesterol, and a fatty acid conjugated elastin-like polypeptide (ELP). The STL had a unilamellar spherical shape with a mean diameter of 160 nm. Doxorubicin (DOX) was encapsulated by the STL using an ammonium sulfate gradient method with a lipid to drug ratio of 1: 0.2 (w/w), resulting in 95% loading efficiency. The STL exhibited better stability than conventional low temperature sensitive liposome (LTSL-lysolipid-based temperature sensitive liposomes; DPPC:MSPC:DSPE-PEG-(2000) = 90: 10: 4) at 37 degrees C in the presence of serum; there was rapid release of doxorubicin in the range of 39-42 degrees C (>= 95% release at 42 degrees C within 10 s). A confocal microscope revealed that DOX encapsulated in STL (STL-DOX) was taken up much better by cell nuclei at 42 degrees C than at 37 degrees C. The difference in cell viability between 37 and 42 degrees C was 63% relative to STL-DOX and 18% for LTSL-DOX. The pharmacokinetics (PK) and antitumor effect of STL-DOX combined with high-intensity focused ultrasound (HIFU) were studied, and compared with LTSL. An in vivo study demonstrated that STL-DOX is highly stable, with a long circulating property (half life = 2.03 +/- 0.77 h) in HIFU-untreated mice, and resulted in significant tumor regression for 2 days after intravenous injection of STL-DOX at 5 mg DOX/kg in combination with HIFU. These results are better than conventional LTSL, for which the blood circulation time is short (0.92 +/- 0.17 h) and inhibition of tumor growth is weak. These results indicate that the properties of stability at 37 degrees C and burst release at 42 degrees C of STL-DOX act synergistically against tumors. (C) 2013 Elsevier B. V. All rights reserved.

키워드

Drug delivery system; Thermosensitive liposome; Elastin-like polypeptide; Heat-triggered drug release; Mild hyperthermia; TARGETED DRUG-DELIVERY; SENSITIVE LIPOSOMES; THERMOSENSITIVE LIPOSOMES; MILD HYPERTHERMIA; MACROMOLECULAR THERAPEUTICS; RELEASE; PERMEABILITY; PEPTIDE; NANOCARRIERS; ACCUMULATION
제목
Novel temperature-triggered liposome with high stability: Formulation, <i>in vitro</i> evaluation, and <i>in vivo</i> study combined with high-intensity focused ultrasound (HIFU)
저자
Park, Sun Min; Kim, Min Sang; Park, Sang-Jun; Park, Eun Sung; Choi, Kyu-Sil; Kim, Young-sun; Kim, Hyun Ryoung
DOI
10.1016/j.jconrel.2013.06.003
발행일
2013-09-28
유형
Article
저널명
Journal of Controlled Release
권
170
호
3
페이지
373 ~ 379